# Contrave Extended-Release

NDC: 51267-890
Generic name: naltrexone hydrochloride and bupropion hydrochloride
Labeler / Manufacturer: Nalpropion Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20141022

FDA application: NDA200063

## Active ingredients

- BUPROPION HYDROCHLORIDE: 90 mg/1
- NALTREXONE HYDROCHLORIDE: 8 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51267-890"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51267-890
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=485ff360-32c8-11df-928b-0002a5d5c51b